Coagulative, fibrinolytic and metabolic pattern in patients with central retinal vein occlusion

Ophthalmologica

Volumn 216, Issue 2, 2002, Pages 108-112

  Fruschelli, Mario ^a,b   Puccetti, L ^a   Bruni, F ^a   Auteri, A ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Central retinal vein occlusion; Coagulation; Fibrinolysis

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD VISCOSITY; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FIBRINOLYSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RISK FACTOR; VISUAL IMPAIRMENT;

ADULT; AGED; BLOOD COAGULATION DISORDERS; FEMALE; FIBRINOGENS, ABNORMAL; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION;

EID: 0036210873     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048308     Document Type: Article

References (28)

1. Natural history and clinical management of central retinal vein occlusion
2. Retinal vein occlusion: C-reactive protein and arterial hypertension
3. Medical conditions underlying recurrence of retinal vein occlusion
4. Abnormal blood viscosity and erythrocyte deformability in retinal vein occlusion
5. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion
6. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases
7. Blood viscosity, coagulation and activated protein C resistance in central retinal vein occlusion: A population controlled study
8. Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion
9. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions
10. Hypercoagulability and high lipoprotein(a) levels in patients with central retinal vein occlusion
11. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: A prospective case-control study
12. Combination of ACE inhibitors and calcium antagonists: A logical approach
13. Methods for evaluation of human fibrinolysis
14. Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade in human plasma
15. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection
16. Thrombophilia: A feature of importance in retinal vein thrombosis?
17. Soluble P-selectin in atherosclerosis: A comparison with endothelial cell and platelet markers
18. The origin of P-selectin as a circulating plasma protein
19. Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide
20. Plasma procarboxypeptidase U in men with coronary artery disease
21. Retinal vascular occlusion and deficiencies in the protein C pathway
22. Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion
23. Coagulation and platelet activation after retinal vein occlusion
24. Screening for activated protein C resistance before oral contraceptive treatment: A pilot study
25. Prevalence of factor V leiden in patients with retinal vein occlusion
26. Factor V leiden and prothrombin 20210 A mutations in patients with central branch retinal vein occlusion
27. Lp(a): An interloper into the fibrinolytic system?
28. Hyperhomocysteinemia, atherosclerosis and thrombosis